The global life science software market is expected to reach a valuation of US$ 13,736 million in 2023. The key growth factors driving the market are increasing research and development, expanding biotech number and size, and increasing cost efficiencies. The overall sales of life science software are projected to grow at a robust CAGR of 7.5% between 2023 and 2033, totaling around US$ 31,151.8 million by the end of 2033.
Life science is a branch of science concerned with the research of living organisms. Biology, anatomy, health sciences, medical sciences, and pharmaceutics are all fields of study in life science. In today's evolving healthcare ecosystem, life science software aids in developing comprehensive, integrated solutions to the life science industry, such as product quality, regulatory compliance, speed, cost-effectiveness, and many others.
| Data Points | Key Statistics |
|---|---|
| Life Science Software Market Size (2023) | US$ 13,736 million |
| Life Science Software Market Revenue Forecast (2033) | US$ 31,151.8 million |
| Life Science Software Market Growth Rate (2023 to 2033) | 7.5% CAGR |
| North America Market Share | 40.5% |
Life science software includes various tools for standardizing workflow and managing documentation to serve the biopharmaceutical, medical technology, generics, and clinical care industries. These programs allow corporations to record, store, and preserve information through images and text. Various types of life science software are available, along with drug identification and affirmation, laboratory management, clinical trial management, and medical device innovation.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Continuous technological innovations, the accessibility of big data in the life science industry, the increasing adoption of analytics techniques in clinics and hospitals as well as for sales and promotion in the pharmaceutical companies, and the burgeoning need for enhanced patient care shipment are some of the major factors driving the expansion of the life science software market.
Furthermore, factors such as an increase in the frequency of chronic diseases, massive pressure to reduce healthcare spending, and a bigger emphasis on value-based medicine all contribute to the significant growth of this market.
However, aspects such as the elevated cost of implementing life science software, complex programming, additional infrastructure, and data management costs limit the expansion of the life science software market.
Principal Consultant
Due to the elevated adoption of cutting-edge technologies and a substantial majority of investments, North America dominates the life science software market. Because of the escalating digitization of healthcare-related work processes and the presence of major healthcare firms implementing this software in these regions, North America is the leading market in the life science software market. It is expected to grow rapidly over the next decade.
The United States is the key industry in North America for life science software. The market in this region will develop faster than South America's. The demand for security, easy access to data, and productive patient information management will aid the growth of the life science software industry. North America is accounting for a market share of 40.5% of the global life science software market.
The European life science software market is expected to grow at a 9% CAGR. During the forecast period, the European life science software sector is predicted to account for the largest share of the global market. Geographically, the European life science software market accounted for a sizable share of the overall in 2020 and is anticipated to grow at a healthy rate during the forecast period.
During the forecast period, the German life science software market is expected to be a lucrative business regional market in Europe. The German market benefits from social advancements such as censuses and technological advancements such as digitization. The growing use of IoT and cloud computing is expected to boost the life science software market. Europe is accounting for a market share of 24% of the global life science software market.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The biopharmaceutical segment's life science software market share will develop significantly during the forecast period. Life science software can benefit biopharmaceutical companies by providing a global healthcare standard. It bolsters the functionalities of logistic partners and collaborates with trading partners such as contract packagers. During the forecast period, these characteristics will drive segment growth.
Manufacturers are adopting various marketing strategies such as new product launches, geographical expansion, mergers and acquisitions, partnerships, and collaboration to identify the interests of potential buyers and create a larger customer base. For instance,
Some of the leading life science software providers include Oracle Corporation, Deloitte, SAP SE, Accelrys Software, Inc., Cegedim SA, Medidata Solution, Inc., Revitas, Inc., Veeva Systems, Inc., Model N, Inc., SAS Institute, Inc., PTC Therapeutics, Inc., TIBCO Software, Inc., and Perceptive Informatics, Inc.
These key life science software providers are adopting various strategies, such as new product launches and approvals, partnerships, collaborations, acquisitions, mergers, etc., to increase their sales and gain a competitive edge in the global life science software market. For instance,
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 7.5% from 2023 to 2032 |
| Expected Market Value (2023) | US$ 13,736 million |
| Anticipated Forecast Value (2033) | US$ 31,151.8 million |
| Base Year for Estimation | 2023 |
| Historical Data | 2018 to 2022 |
| Forecast Period | 2023 to 2033 |
| Quantitative Units | Revenue in US$ million and CAGR from 2023 to 2033 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered |
|
| Regions Covered |
|
| Key Countries Profiled |
|
| Key Companies Profiled |
|
| Customization | Available Upon Request |
The market in 2023 is valued at US$ 13,736 million.
The market is estimated to reach US$ 31,151.8 million by 2033.
The market is likely to expand at a 7.5% CAGR through 2033.
The market rose at a 6% CAGR from 2018 to 2022.
North America accounts for 40.5% of revenue in 2023.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Application, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2023 to 2033
5.3.1. for Research and Development
5.3.2. for Clinical Trials
5.3.3. for Drug Safety
5.3.4. for Sales and Marketing Support
5.3.5. for Regulatory Compliance
5.3.6. for Supply Chain Analytics
5.4. Y-o-Y Growth Trend Analysis By Application, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Application, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By End User, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2023 to 2033
6.3.1. for Healthcare Institutes
6.3.2. for Biopharmaceutical Industry
6.3.3. for Medical Devices Industry
6.3.4. for Medical Research Centers
6.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Deployment
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) Analysis By Deployment, 2018 to 2022
7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Deployment, 2023 to 2033
7.3.1. On-Premise Deployment
7.3.2. Hosted Deployment
7.4. Y-o-Y Growth Trend Analysis By Deployment, 2018 to 2022
7.5. Absolute $ Opportunity Analysis By Deployment, 2023 to 2033
8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022
8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033
8.3.1. North America
8.3.2. Latin America
8.3.3. Western Europe
8.3.4. Eastern Europe
8.3.5. South Asia and Pacific
8.3.6. East Asia
8.3.7. Middle East and Africa
8.4. Market Attractiveness Analysis By Region
9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. USA
9.2.1.2. Canada
9.2.2. By Application
9.2.3. By End User
9.2.4. By Deployment
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Application
9.3.3. By End User
9.3.4. By Deployment
9.4. Key Takeaways
10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Rest of Latin America
10.2.2. By Application
10.2.3. By End User
10.2.4. By Deployment
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Application
10.3.3. By End User
10.3.4. By Deployment
10.4. Key Takeaways
11. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. UK
11.2.1.3. France
11.2.1.4. Spain
11.2.1.5. Italy
11.2.1.6. Rest of Western Europe
11.2.2. By Application
11.2.3. By End User
11.2.4. By Deployment
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Application
11.3.3. By End User
11.3.4. By Deployment
11.4. Key Takeaways
12. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. Poland
12.2.1.2. Russia
12.2.1.3. Czech Republic
12.2.1.4. Romania
12.2.1.5. Rest of Eastern Europe
12.2.2. By Application
12.2.3. By End User
12.2.4. By Deployment
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Application
12.3.3. By End User
12.3.4. By Deployment
12.4. Key Takeaways
13. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. India
13.2.1.2. Bangladesh
13.2.1.3. Australia
13.2.1.4. New Zealand
13.2.1.5. Rest of South Asia and Pacific
13.2.2. By Application
13.2.3. By End User
13.2.4. By Deployment
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Application
13.3.3. By End User
13.3.4. By Deployment
13.4. Key Takeaways
14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Country
14.2.1.1. China
14.2.1.2. Japan
14.2.1.3. South Korea
14.2.2. By Application
14.2.3. By End User
14.2.4. By Deployment
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Application
14.3.3. By End User
14.3.4. By Deployment
14.4. Key Takeaways
15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
15.2.1. By Country
15.2.1.1. GCC Countries
15.2.1.2. South Africa
15.2.1.3. Israel
15.2.1.4. Rest of MEA
15.2.2. By Application
15.2.3. By End User
15.2.4. By Deployment
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Application
15.3.3. By End User
15.3.4. By Deployment
15.4. Key Takeaways
16. Key Countries Market Analysis
16.1. USA
16.1.1. Pricing Analysis
16.1.2. Market Share Analysis, 2022
16.1.2.1. By Application
16.1.2.2. By End User
16.1.2.3. By Deployment
16.2. Canada
16.2.1. Pricing Analysis
16.2.2. Market Share Analysis, 2022
16.2.2.1. By Application
16.2.2.2. By End User
16.2.2.3. By Deployment
16.3. Brazil
16.3.1. Pricing Analysis
16.3.2. Market Share Analysis, 2022
16.3.2.1. By Application
16.3.2.2. By End User
16.3.2.3. By Deployment
16.4. Mexico
16.4.1. Pricing Analysis
16.4.2. Market Share Analysis, 2022
16.4.2.1. By Application
16.4.2.2. By End User
16.4.2.3. By Deployment
16.5. Germany
16.5.1. Pricing Analysis
16.5.2. Market Share Analysis, 2022
16.5.2.1. By Application
16.5.2.2. By End User
16.5.2.3. By Deployment
16.6. UK
16.6.1. Pricing Analysis
16.6.2. Market Share Analysis, 2022
16.6.2.1. By Application
16.6.2.2. By End User
16.6.2.3. By Deployment
16.7. France
16.7.1. Pricing Analysis
16.7.2. Market Share Analysis, 2022
16.7.2.1. By Application
16.7.2.2. By End User
16.7.2.3. By Deployment
16.8. Spain
16.8.1. Pricing Analysis
16.8.2. Market Share Analysis, 2022
16.8.2.1. By Application
16.8.2.2. By End User
16.8.2.3. By Deployment
16.9. Italy
16.9.1. Pricing Analysis
16.9.2. Market Share Analysis, 2022
16.9.2.1. By Application
16.9.2.2. By End User
16.9.2.3. By Deployment
16.10. Poland
16.10.1. Pricing Analysis
16.10.2. Market Share Analysis, 2022
16.10.2.1. By Application
16.10.2.2. By End User
16.10.2.3. By Deployment
16.11. Russia
16.11.1. Pricing Analysis
16.11.2. Market Share Analysis, 2022
16.11.2.1. By Application
16.11.2.2. By End User
16.11.2.3. By Deployment
16.12. Czech Republic
16.12.1. Pricing Analysis
16.12.2. Market Share Analysis, 2022
16.12.2.1. By Application
16.12.2.2. By End User
16.12.2.3. By Deployment
16.13. Romania
16.13.1. Pricing Analysis
16.13.2. Market Share Analysis, 2022
16.13.2.1. By Application
16.13.2.2. By End User
16.13.2.3. By Deployment
16.14. India
16.14.1. Pricing Analysis
16.14.2. Market Share Analysis, 2022
16.14.2.1. By Application
16.14.2.2. By End User
16.14.2.3. By Deployment
16.15. Bangladesh
16.15.1. Pricing Analysis
16.15.2. Market Share Analysis, 2022
16.15.2.1. By Application
16.15.2.2. By End User
16.15.2.3. By Deployment
16.16. Australia
16.16.1. Pricing Analysis
16.16.2. Market Share Analysis, 2022
16.16.2.1. By Application
16.16.2.2. By End User
16.16.2.3. By Deployment
16.17. New Zealand
16.17.1. Pricing Analysis
16.17.2. Market Share Analysis, 2022
16.17.2.1. By Application
16.17.2.2. By End User
16.17.2.3. By Deployment
16.18. China
16.18.1. Pricing Analysis
16.18.2. Market Share Analysis, 2022
16.18.2.1. By Application
16.18.2.2. By End User
16.18.2.3. By Deployment
16.19. Japan
16.19.1. Pricing Analysis
16.19.2. Market Share Analysis, 2022
16.19.2.1. By Application
16.19.2.2. By End User
16.19.2.3. By Deployment
16.20. South Korea
16.20.1. Pricing Analysis
16.20.2. Market Share Analysis, 2022
16.20.2.1. By Application
16.20.2.2. By End User
16.20.2.3. By Deployment
16.21. GCC Countries
16.21.1. Pricing Analysis
16.21.2. Market Share Analysis, 2022
16.21.2.1. By Application
16.21.2.2. By End User
16.21.2.3. By Deployment
16.22. South Africa
16.22.1. Pricing Analysis
16.22.2. Market Share Analysis, 2022
16.22.2.1. By Application
16.22.2.2. By End User
16.22.2.3. By Deployment
16.23. Israel
16.23.1. Pricing Analysis
16.23.2. Market Share Analysis, 2022
16.23.2.1. By Application
16.23.2.2. By End User
16.23.2.3. By Deployment
17. Market Structure Analysis
17.1. Competition Dashboard
17.2. Competition Benchmarking
17.3. Market Share Analysis of Top Players
17.3.1. By Regional
17.3.2. By Application
17.3.3. By End User
17.3.4. By Deployment
18. Competition Analysis
18.1. Competition Deep Dive
18.1.1. Oracle Corporation
18.1.1.1. Overview
18.1.1.2. Product Portfolio
18.1.1.3. Profitability by Market Segments
18.1.1.4. Sales Footprint
18.1.1.5. Strategy Overview
18.1.1.5.1. Marketing Strategy
18.1.2. Deloitte
18.1.2.1. Overview
18.1.2.2. Product Portfolio
18.1.2.3. Profitability by Market Segments
18.1.2.4. Sales Footprint
18.1.2.5. Strategy Overview
18.1.2.5.1. Marketing Strategy
18.1.3. SAP SE
18.1.3.1. Overview
18.1.3.2. Product Portfolio
18.1.3.3. Profitability by Market Segments
18.1.3.4. Sales Footprint
18.1.3.5. Strategy Overview
18.1.3.5.1. Marketing Strategy
18.1.4. Accelrys Software Inc.
18.1.4.1. Overview
18.1.4.2. Product Portfolio
18.1.4.3. Profitability by Market Segments
18.1.4.4. Sales Footprint
18.1.4.5. Strategy Overview
18.1.4.5.1. Marketing Strategy
18.1.5. Cegedim SA
18.1.5.1. Overview
18.1.5.2. Product Portfolio
18.1.5.3. Profitability by Market Segments
18.1.5.4. Sales Footprint
18.1.5.5. Strategy Overview
18.1.5.5.1. Marketing Strategy
18.1.6. Medidata Solution Inc.
18.1.6.1. Overview
18.1.6.2. Product Portfolio
18.1.6.3. Profitability by Market Segments
18.1.6.4. Sales Footprint
18.1.6.5. Strategy Overview
18.1.6.5.1. Marketing Strategy
18.1.7. Revitas Inc.
18.1.7.1. Overview
18.1.7.2. Product Portfolio
18.1.7.3. Profitability by Market Segments
18.1.7.4. Sales Footprint
18.1.7.5. Strategy Overview
18.1.7.5.1. Marketing Strategy
18.1.8. Veeva Systems Inc.
18.1.8.1. Overview
18.1.8.2. Product Portfolio
18.1.8.3. Profitability by Market Segments
18.1.8.4. Sales Footprint
18.1.8.5. Strategy Overview
18.1.8.5.1. Marketing Strategy
18.1.9. Model N Inc.
18.1.9.1. Overview
18.1.9.2. Product Portfolio
18.1.9.3. Profitability by Market Segments
18.1.9.4. Sales Footprint
18.1.9.5. Strategy Overview
18.1.9.5.1. Marketing Strategy
18.1.10. SAS Institute Inc.
18.1.10.1. Overview
18.1.10.2. Product Portfolio
18.1.10.3. Profitability by Market Segments
18.1.10.4. Sales Footprint
18.1.10.5. Strategy Overview
18.1.10.5.1. Marketing Strategy
18.1.11. PTC Therapeutics Inc.
18.1.11.1. Overview
18.1.11.2. Product Portfolio
18.1.11.3. Profitability by Market Segments
18.1.11.4. Sales Footprint
18.1.11.5. Strategy Overview
18.1.11.5.1. Marketing Strategy
18.1.12. TIBCO Software Inc.
18.1.12.1. Overview
18.1.12.2. Product Portfolio
18.1.12.3. Profitability by Market Segments
18.1.12.4. Sales Footprint
18.1.12.5. Strategy Overview
18.1.12.5.1. Marketing Strategy
18.1.13. Perceptive Informatics Inc.
18.1.13.1. Overview
18.1.13.2. Product Portfolio
18.1.13.3. Profitability by Market Segments
18.1.13.4. Sales Footprint
18.1.13.5. Strategy Overview
18.1.13.5.1. Marketing Strategy
19. Assumptions & Acronyms Used
20. Research Methodology
Explore Technology Insights
View Reports
Life Science Software Market
